Show simple item record

dc.contributor.authorMacklin-Doherty, A
dc.date.accessioned2019-04-10T09:50:20Z
dc.date.issued2018-01-01
dc.identifier.citationEcancermedicalscience, 2018, 12 pp. ed83 - ?
dc.identifier.issn1754-6605
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3173
dc.identifier.eissn1754-6605
dc.identifier.doi10.3332/ecancer.2018.ed83
dc.description.abstractAccountability of service delivery is becoming increasingly complex and never has this been more apparent than in the field of Oncology. Cancer care has an unrivalled level of complexity not only in the heterogeneity of management of the disease itself but increasingly in the myriad of service providers, specialities, policymakers and regulatory bodies overseeing its delivery. The stepwise series of changes to NHS structures over recent decades has had an enormous impact on our ability to answer key questions which lie at the heart of accountability: who is making the key decisions about changes to cancer care delivery? What are these reforms achieving? How can they be influenced? It is only through clear and transparent decision-making that we may have any hope of implementing, monitoring and influencing the effects of evidence-based change. However, with growing complexity of service structures and an increasing number of bodies developing ambitious and complex strategies, in a context of resource restraint and system pressures, it has become very difficult to answer these questions clearly. This increasing lack of clarity and transparency around such fundamental questions may mean that, despite there being such a pressing need and apparent desire for accountability in cancer care, paradoxically we may actually be deviating further and further away from this. Perhaps it is time for less complexity and for the decision-makers to get back to some fundamental principles which clinicians have embraced in evidence-based medicine: what is being done and by whom? Is this change beneficial and if not how can we influence change?
dc.formatElectronic-eCollection
dc.format.extented83 - ?
dc.languageeng
dc.language.isoeng
dc.publisherEcancer Global Foundation
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleAccountability in the NHS: the impact on cancer care.
dc.typeJournal Article
rioxxterms.versionofrecord10.3332/ecancer.2018.ed83
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEcancermedicalscience
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Aetiological Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Aetiological Epidemiology
pubs.publication-statusPublished
pubs.volume12
pubs.embargo.termsNo embargo
icr.researchteamAetiological Epidemiology
dc.contributor.icrauthorMacklin-Doherty, Aislinn


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0